Aristotle University Of Thessaloniki (AUTH)
Ανοσιακή απάντηση ασθενών με αιμορραγικό πυρετό με νεφρική προσβολή και ασθενών με αιμορραγικό πυρετό Κριμαίας-Κονγκό
Abstract
dc:descriptionTwo viral hemorrhagic fevers have been reported in Greece, hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses (in Greece mainly by Dobrava-Belgrade virus, DOBV) and Crimean-Congo hemorrhagic fever (CCHF) caused by CCHF virus (CCHFV). Even though the pathogenesis of these diseases is not fully understood, the activation of immune response system and the secretion of cytokines, known as “cytokine storm”, is thought to play a major role. Aim of the present thesis was to investigate the immune response in patients with HFRS and in patients with CCHF, focused on the evaluation of the cytokine patterns in relation with the clinical course and/or the outcome of the disease.Materials and methods: The study included 54 blood samples collected 5-70 days (mean 13.5 days) after onset of the disease from 30 HFRS patients (26 males) aged 17-70 years (median age 35.5 years), and 29 blood samples collected 1-9 days (mean 4.9 days) after onset of the disease from 29 CCHF patients (12 males) aged 4-67 years (median age 44 years). One HFRS case was fatal and 17 were considered as severe, while two CCHF cases were fatal and 8 were considered as severe. The samples were divided into groups according to the clinical course, the outcome of the disease and the days collected post symptoms' onset (day of illness). Serum samples from 16 apparently healthy individuals (9 males) aged 18-65 years (median age 45 years) were included in the study as control group. IgM and IgG antibodies against hantaviruses and CCHFV were detected using indirect immunofluorescent assay (IFA) and ELISA, while viral RNA was detected using RT-nested PCR and real time RT-PCR. The serum levels of 27 cytokines [interleukin (IL)-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, eotaxin, FGF-b, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1a, MIP-1b, PDGF-bb, RANTES, TNF-α and VEGF] were estimated using the BioPlexTM Suspension Array System (Bio-Rad Laboratories, CA).Results: IgM and IgG antibodies against hantaviruses were detected in all HFRS patients; hantavirus RNA was detected by RT-nested PCR in 22/29 (75.9%) samples which had been taken up to 16th day of illness. Sequencing of the PCR products showed that in all cases the causative agent was DOBV. During the first two weeks of illness, and compared to the control group, significantly elevated IL-1ra, IL-6, IL-8, IL-9, IL-10, GM-CSF, ΙΡ-10, ΜΙΡ-1b, PDGF, TNF-α and VEGF levels were observed in the severe cases, while in the non-severe cases, IL-13 and TNF-α levels were significantly elevated (p<0.05). In the two samples from the fatal case it was seen that the levels of IL-1b, IL-4, IL-7 IL-13, IL-17, MIP-1a and PDGF were decreased, while the levels of IL-6, IL-8, IL-10, IP-10 and MIP-1b were increased (p<0.05). A strong immune response was seen during the first week of illness, especially in severe cases, while the response in non-severe cases was weaker and delayed. During the 3rd week of illness or later and compared to the control group, serum levels of IL-9, IL-10, ΜΙΡ-1b, PDGF and VEGF remained elevated in severe cases, while levels of IL-6, IL-8, IL-10, IP-10 and MIP-1a remained elevated in the two samples from the fatal case (up to the death). In contrast in non-severe cases, the serum levels of most cytokines were similar to those of the control group. In all groups, IP-10 was increased and RANTES was decreased (p<0.05). Univariate logistic regression analysis showed that high serum levels of IL-8, IL-10 and VEGF were associated with disease severity, while multivariate regression analysis revealed VEGF as the most independent factor.Among the 29 CCHF patients, IgM antibodies were detected in 14 (48.3%), while IgG antibodies were not detected. Real-time RT-PCR was positive in all samples, while RT-nested PCR was positive in 23/29 (79.3%) samples. Compared to the control group, significantly elevated IL-6, IL-8, IL-9, IL-10, IL-13, GM-CSF, IFN-γ και IP-10 levels were found in severe cases (p<0,05), while in non-severe cases, increased levels were seen in IL-1ra, IL-6, IL-8, IL-10, IP-10, MCP-1 and VEGF (p<0,05). Levels of IL-1b, IL-6, IL-8, IL-9, IL-10, IL-15, eotaxin, ΙΡ-10, MCP-1 and TNF-α were increased in the fatal cases (p<0.05). In all groups, IL-6, IL-8, IL-10 and IP-10 were increased, with the highest levels being observed in the fatal cases (p<0.05). Among survivors, IP-10 and MCP-1 were higher in severe than in non-severe cases (p<0.05). Significantly higher levels of IL-1b, IL-6, IL-8, IL-9, IL-10, IL-15, ΙΡ-10, MCP-1 and TNF-α were observed in fatal than in non-fatal cases (p<0.05). The viral load was positively correlated with IL-10, IP-10, and MCP-1 levels, and negatively correlated with the ratio IL- 12/IL-10 (p<0.05). Multivariate logistic regression analysis showed that viral load and IP-10 were associated with disease severity and fatal outcome, while multivariate analysis revealed IP-10 as the most independent factor.Comparing the cytokine levels between HFRS and CCHF, several similarities and differences were noticed. No significant differences were found among fatal cases, while among survivors, mean levels of IL-8, IL-9, IL-10 and eotaxin were higher in HFRS patients (p<0.05). Compared to the control group, mean level of RANTES was decreased in both HFRS and CCHF patients (p<0.05). Similarly, in fatal HFRS and CCHF cases IP-10 was increased and IL-4 was decreased (p<0.05). Levels of IL-10 were increased only in fatal HFRS cases (p<0.05), while in fatal CCHF cases, MCP-1 and TNF-α were significantly increased and IL-12 was decreased (p<0.05). Mean levels of IL-6 and IL-8 were increased in HFRS cases and in fatal CCHF cases (p<0.05). VEGF was increased only in HFRS survivors (p<0.05). Conclusions: The present study showed that the immune response in HFRS and CCHF patients is time dependent and affects and is affected by the course and the outcome of the disease. Immune response in severe cases is stronger than in non-severe cases. VEGF and IP-10 can serve as possible biomarkers of disease severity in HFRS and in CCHF, respectively. The similarities of the immune response in HFRS and in CCHF suggest common pathophysiology of viral hemorrhagic fevers, while the observed differences are likely due to variations of interactions between viruses and the target host cells. The results of the study could be the basis of future research aiming to treatment and vaccine design.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsergouli, Katerina
- Τσεργούλη, Αικατερίνη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40450